165 related articles for article (PubMed ID: 11824891)
1. Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature.
Brock S; Ellison D; Frankel J; Davis C; Illidge T
Clin Oncol (R Coll Radiol); 2001; 13(6):476-9. PubMed ID: 11824891
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
3. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
4. Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.
Widdess-Walsh P; Tavee JO; Schuele S; Stevens GH
J Neurooncol; 2003 Jun; 63(2):187-90. PubMed ID: 12825823
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
7. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
Tanaka M; Tanaka K
Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
[TBL] [Abstract][Full Text] [Related]
8. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
10. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
Matsushita H; Kodama S; Aoki Y; Tanaka K; Tanaka K; Saito N
Gynecol Obstet Invest; 1998; 45(2):140-3. PubMed ID: 9517809
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma.
Levite R; Fishman A; Kesler A; Altaras M; Gadoth N
Int J Gynecol Cancer; 2001; 11(2):169-71. PubMed ID: 11328418
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
[TBL] [Abstract][Full Text] [Related]
14. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
17. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
18. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration.
Erez Y; Rojansky N; Shveiky D; Ben-Meir A; Benshushan A
Gynecol Oncol; 2007 Jun; 105(3):826-7. PubMed ID: 17428523
[TBL] [Abstract][Full Text] [Related]
20. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration.
Stich O; Graus F; Rasiah C; Rauer S
J Neuroimmunol; 2003 Aug; 141(1-2):165-9. PubMed ID: 12965268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
